PFRM3.SA
Strong BuyFull HouseAI neutralProfarma Distribuidora de Produtos Farmacêuticos S.A. · Healthcare · Brazil · $176M
BRL 7.70 +3.1% · close 2 Oct · scored 3 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Profarma is a prominent Brazilian pharmaceutical distributor and retail drugstore operator trading at very cheap valuation multiples. While forward earnings revisions have turned slightly positive, operating margins in wholesale pharmaceutical distribution are structurally thin and market momentum is subdued. The lack of stronger momentum or insider buying suggests a patient monitoring approach.
ABOUT PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.
Read
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It offers pharmaceutical, personal hygiene, and beauty products.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 7.8B | 8.7B | 10.2B | 11.5B | 13.6% | 12.5B |
| EPS (BRL) | 0.66 | 0.57 | 0.93 | 0.97 | 13.7% | 1.26 |
| Shares | 122.6M | 122.6M | 122.6M | 122.6M | -0.0% | 122.6M |
| Debt | 1.0B | 1.1B | 1.2B | 1.4B | 11.0% | 1.9B |
| Equity | 1.2B | 1.2B | 1.3B | 1.3B | 4.2% | — |
| Op CF | 126.3M | 260.9M | 497.1M | 459.7M | 53.8% | 573.1M |
| Inv CF | -21.7M | -96.6M | -136.8M | -176.1M | — | — |
| Fin CF | -109.8M | -153.8M | -324.4M | -278.0M | — | — |
Calmer than 51% of stocks we rank over the past year (41% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PFRM3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A.(you) | $176M | 98 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $268M | 98 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $323M | 95 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $378M | 97 | Strong Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $89M | 89 | Strong Buy |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $58M | 91 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $459M | 85 | Strong Buy |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $522M | 82 | Strong Buy |
| FLRY3.SA | Fleury S.A. | $2.3B | 99 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $782M | 74 | Buy |
Peer medians: ROE 10.6% · P/E 14.2x · Gross margin 30.7%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.